Windtree Therapeutics Stock Price Prediction
| WINT Stock | USD 5.68 0.23 4.22% |
Oversold Vs Overbought
48
Oversold | Overbought |
Windtree Therapeutics stock price prediction is an act of determining the future value of Windtree Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Windtree Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Windtree Therapeutics and does not consider all of the tangible or intangible factors available from Windtree Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Windtree Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Windtree Therapeutics' stock price prediction:EPS Estimate Current Year (0.97) | EPS Estimate Next Year (0.66) | Wall Street Target Price 3 | EPS Estimate Current Quarter (0.94) | Quarterly Revenue Growth (1.00) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Windtree Therapeutics based on different types of headlines from major news networks to social media. The Windtree stock price prediction module provides an analysis of price elasticity to changes in media outlook on Windtree Therapeutics over a specific investment horizon. Using Windtree Therapeutics hype-based prediction, you can estimate the value of Windtree Therapeutics from the perspective of Windtree Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Windtree Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Windtree Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Windtree because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Windtree Therapeutics after-hype prediction price | USD 8.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Windtree |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Windtree Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Windtree Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Windtree Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Windtree Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Windtree Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Windtree Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Windtree Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Windtree Therapeutics' historical news coverage. Windtree Therapeutics' after-hype downside and upside margins for the prediction period are 3.48 and 13.48, respectively. We have considered Windtree Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Windtree Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of Windtree Therapeutics is based on 3 months time horizon.
Windtree Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Windtree Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Windtree Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Windtree Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 4.97 | 2.52 | 0.48 | 9 Events / Month | 3 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.68 | 8.22 | 44.79 |
|
Windtree Therapeutics Hype Timeline
Windtree Therapeutics is at this time traded for 5.68. The entity has historical hype elasticity of 2.52, and average elasticity to hype of competition of 0.48. Windtree is estimated to increase in value after the next headline, with the price projected to jump to 8.224 or above. The average volatility of media hype impact on the company the price is about 92.55%. The price appreciation on the next news is projected to be 44.79%, whereas the daily expected return is at this time at -0.47%. The volatility of related hype on Windtree Therapeutics is about 484.03%, with the expected price after the next announcement by competition of 6.16. The company currently holds 16.83 M in liabilities with Debt to Equity (D/E) ratio of 0.95, which is about average as compared to similar companies. Windtree Therapeutics has a current ratio of 2.42, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Windtree Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Windtree Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Windtree Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Windtree to invest in growth at high rates of return. When we think about Windtree Therapeutics' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next estimated press release will be in about 9 days. Check out Windtree Therapeutics Basic Forecasting Models to cross-verify your projections.Windtree Therapeutics Related Hype Analysis
Having access to credible news sources related to Windtree Therapeutics' direct competition is more important than ever and may enhance your ability to predict Windtree Therapeutics' future price movements. Getting to know how Windtree Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Windtree Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NRBO | Neurobo Pharmaceuticals | (0.15) | 9 per month | 5.28 | 0.02 | 9.12 | (10.81) | 81.23 | |
| PALI | Palisade Bio | 5.22 | 9 per month | 9.15 | (0) | 8.84 | (10.98) | 119.62 | |
| LIXT | Lixte Biotechnology Holdings | 0.05 | 5 per month | 5.04 | 0.14 | 12.55 | (6.92) | 71.97 | |
| ATXI | Avenue Therapeutics | 0.01 | 6 per month | 4.07 | (0.01) | 7.69 | (7.14) | 32.46 | |
| CFRX | ContraFect Corp | 0 | 2 per month | 0.00 | (0.13) | 15.38 | (23.29) | 71.74 |
Windtree Therapeutics Additional Predictive Modules
Most predictive techniques to examine Windtree price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Windtree using various technical indicators. When you analyze Windtree charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Windtree Therapeutics Predictive Indicators
The successful prediction of Windtree Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Windtree Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Windtree Therapeutics based on analysis of Windtree Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Windtree Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Windtree Therapeutics's related companies. | 2023 | 2024 (projected) | Graham Number | 10.15 | 9.64 | Receivables Turnover | 6.66 | 6.33 |
Story Coverage note for Windtree Therapeutics
The number of cover stories for Windtree Therapeutics depends on current market conditions and Windtree Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Windtree Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Windtree Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Windtree Therapeutics Short Properties
Windtree Therapeutics' future price predictability will typically decrease when Windtree Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Windtree Therapeutics often depends not only on the future outlook of the potential Windtree Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Windtree Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.9 M | |
| Cash And Short Term Investments | 4.3 M |
Check out Windtree Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Windtree Stock analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Windtree Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Windtree Therapeutics. If investors know Windtree will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Windtree Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.32) | Quarterly Revenue Growth (1.00) | Return On Assets (0.30) | Return On Equity (3.03) |
The market value of Windtree Therapeutics is measured differently than its book value, which is the value of Windtree that is recorded on the company's balance sheet. Investors also form their own opinion of Windtree Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Windtree Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Windtree Therapeutics' market value can be influenced by many factors that don't directly affect Windtree Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Windtree Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Windtree Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Windtree Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.